# ProtoKinetix, Inc.: overview PKTX · OTC · CIK 1128189 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/pktx.md) · [Financials](/companies/pktx/financials.md) · [Filings](/companies/pktx/filings.md) · [Insiders](/companies/pktx/insiders.md) Latest reported revenue: [$0](/filings/0001079973-15-000278.md) for Q4 FY2014, three months to 2014-12-31, from the 10-K filed Apr 14, 2015 (XBRL us-gaap:Revenues, accession 0001079973-15-000278). ## Last eight quarters | Line item | Unit | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $ | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Net margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Diluted EPS | $ per share | [0.00](/filings/0001079973-25-000816.md) | [0.00](/filings/0001079973-25-001254.md) | [0.00](/filings/0001079973-25-001708.md) | not reported | [0.00](/filings/0001079973-25-000816.md) | [0.00](/filings/0001079973-25-001254.md) | [0.00](/filings/0001079973-25-001708.md) | not reported | | Free cash flow | $ | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | - Revenue. XBRL not reported. - Gross margin (gross profit / revenue). XBRL not reported. - Operating margin (operating income / revenue). XBRL not reported. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss. Derived values: 12-month figure less the 9-month figure. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities. Derived values: 6-month figure less the 3-month figure; 9-month figure less the 6-month figure; 12-month figure less the 9-month figure. ## Last five fiscal years | Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) | | --- | --- | ---: | ---: | ---: | ---: | ---: | | Revenue | $ | not reported | not reported | not reported | not reported | not reported | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | not reported | not reported | not reported | not reported | not reported | | Net margin | % | not reported | not reported | not reported | not reported | not reported | | Diluted EPS | $ per share | [0.00](/filings/0001079973-22-000230.md) | [(0.01)](/filings/0001079973-24-000403.md) | [(0.01)](/filings/0001079973-25-000516.md) | [0.00](/filings/0001079973-26-001218.md) | [0.00](/filings/0001079973-26-001218.md) | | Free cash flow | $ | not reported | not reported | not reported | not reported | not reported | - Revenue. XBRL not reported. - Gross margin (gross profit / revenue). XBRL not reported. - Operating margin (operating income / revenue). XBRL not reported. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareBasicAndDiluted; Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities. Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing. ## Insider purchases and sales The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/pktx/insiders.md) None in coverage. ## Funds that report holding it From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md) | Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before | | --- | --- | ---: | ---: | --- | --- | | [Williams Jones Wealth Management, LLC.](/funds/1788587.md) | 2026-06-30 | $200 | 20,000 | | Unchanged | ## Recent filings [All 364 filings](/companies/pktx/filings.md) | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2026-09-03 | 17:16 ET | [10-K](/filings/0001079973-26-001218.md) | Annual report, period 2025-12-31 | 0001079973-26-001218 | | 2026-06-17 | 17:28 ET | [8-K](/filings/0001079973-26-000855.md) | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001079973-26-000855 | | 2025-11-21 | 11:57 ET | [8-K](/filings/0001553350-25-000111.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001553350-25-000111 | | 2025-11-19 | 17:19 ET | [8-K/A](/filings/0001079973-25-001802.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001079973-25-001802 | | 2025-11-17 | 08:36 ET | [8-K](/filings/0001079973-25-001778.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001079973-25-001778 | | 2025-11-13 | 16:06 ET | [10-Q](/filings/0001079973-25-001708.md) | Quarterly report, period 2025-09-30 | 0001079973-25-001708 | | 2025-10-10 | 16:58 ET | [8-K](/filings/0001079973-25-001594.md) | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001079973-25-001594 | | 2025-09-15 | 17:00 ET | [DEF 14A](/filings/0001079973-25-001456.md) | Proxy statement, period 2025-10-05 | 0001079973-25-001456 | | 2025-08-13 | 13:30 ET | [10-Q](/filings/0001079973-25-001254.md) | Quarterly report, period 2025-06-30 | 0001079973-25-001254 | | 2025-05-15 | 14:29 ET | [10-Q](/filings/0001079973-25-000816.md) | Quarterly report, period 2025-03-31 | 0001079973-25-000816 | ## Latest annual report [Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001079973-26-001218.md), filed Sep 3, 2026. ## Forecast league Not in this season’s league. [This season’s league](/leagues.md) ## About the filer - CIK: 1128189 - Tickers: PKTX - Exchange: OTC - SIC code: 2834 Pharmaceutical Preparations - State of incorporation: NV - Filer category: Non-accelerated filer
Smaller reporting company Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:34 ET. No prices; not investment advice.